Zhejiang University

This study looked at whether adding an immunotherapy drug (Anti-PD-1) to standard chemotherapy can help people with locally advanced or borderline resectable pancreatic cancer. About 392 participants were randomly assigned to get either chemo alone or chemo plus the immunotherapy…

This early-phase study tested a new immune cell therapy called ThisCART19A in 10 adults with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL), a hard-to-treat blood cancer. The main goals were to check safety and find the right dose by monitoring side effects an…

This study tested whether a low dose of the drug chidamide, given after a stem cell transplant, can help prevent T-cell acute lymphoblastic leukemia or T-cell lymphoma from coming back. Forty-four participants received the treatment to see how long they stayed cancer-free and wha…

This study tested a new device called the COMBO Endoscopy Oropharyngeal Airway in 104 adults having a lung exam (bronchoscopy) under sedation. The device combines oxygen support, breathing monitoring, and a bite block to prevent low oxygen levels. The goal was to see if it reduce…